Petersburg Institute of Bioregulation and Gerontology in the late 1980s and 1990s as part of a broader research programme on short peptide bioregulators
Introducing retatrutide Retatrutide is a new medication that targets the glucose-dependent insulinotropic polypeptide (GIP receptor), glucagon-like peptide-1 (GLP-1), and glucagon receptors (GCG receptors)
Enhanced protein intake on maintaining muscle mass, strength, and physical function in adults with overweight/obesity: A systematic review and meta-analysis J Nutr
Cost/kilogram of weight loss at 72W was 102.86, 85.41, and 89.24 for 5, 10, and 15 mg, respectively
Chen J, Xie J-J, Shi K-S, Gu Y-T, Wu C-C, Xuan J, et al